ArticlePapillomavirus research (Amsterdam, Netherlands)2019

Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries.

Asmaa Gohar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.